| Application no. and date | 21727186.5 (espacenet) (Federated) (European Patent Register), 20210528 | | Patent/reg. no. and date | DK/EP 3934653, 20221109 | | Publication date | 20220112 | | Priority no. and date | EP 20177451, 20200529, EP 20184767, 20200708, EP 20195740, 20200911, EP 21171333, 20210429 | | EP pub. no. and date |
EP 3934653 20220112 | | Effective date | | | Applicant/owner | CEBINA GmbH, Karl-Farkas-Gasse 22
1030 Vienna, AT | | Applicant ref. no. | P338829.DK.01//WOODJ | | Inventor | NAGY, Eszter,
1070 Vienna, AT,
NAGY, Gábor,
9400 Sopron, HU,
KONRAT, Robert,
1040 Vienna, AT,
SZIJARTO, Valeria,
1160 Wien, AT | | Representative | Murgitroyd & Company, Mannerheimvägen 12 B 5th floor
FI-00100 Helsinki, FI | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61P 11/00 (2006.01) , A61P 31/14 (2006.01) | | Title | Azelastin som antiviral behandling | | Int. application no. | EP2021064338 | | Int. publication no. | WO2021239943 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
